E
N. W. J. Ang et al.
Paper
Synthesis
13C NMR (126 MHz, CDCl3): δ = 152.2, 120.2 (br C-B), 83.3, 44.5, 32.9,
11B NMR (160 MHz, CDCl3): δ = 33.96.
31.2, 24.9.
11B NMR (160 MHz, CDCl3): δ = 29.39.
4,4,5,5-Tetramethyl-2-(4-phenyl-1-butyl)-1,3,2-dioxaborolane
(2n)
According to General Procedure A, 4-phenyl-1-butene (1.00 mmol,
0.150 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 18 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2n (188.7 mg, 0.730 mmol, 73%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 7.29–7.24 (m, 2 H), 7.20–7.14 (m, 3 H),
2.63–2.58 (m, 2 H), 1.68–1.59 (m, 2 H), 1.53–1.44 (m, 2 H), 1.25 (s,
12 H), 0.82 (t, J = 7.8 Hz, 2 H).
(E)-4,4,5,5-Tetramethyl-2-(cyclopropyl-1-enyl)-1,3,2-dioxaboro-
lane (2j)
According to General Procedure A, cyclopropylacetylene (1.00 mmol,
0.085 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 1 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2j (164.3 mg, 0.850 mmol, 85%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 6.09 (ddd, J = 17.8, 9.3, 1.1 Hz, 1 H),
5.50 (d, J = 17.8 Hz, 1 H), 1.58–1.49 (m, 1 H), 1.27 (s, 12 H), 0.84–0.79
(m, 2 H), 0.57–0.52 (m, 2 H).
13C NMR (126 MHz, CDCl3): δ = 143.1, 128.5, 128.3, 125.6, 83.0, 35.9,
34.3, 25.0, 23.9, 11.3 (br C-B).
13C NMR (126 MHz, CDCl3): δ = 158.7, 115.4 (br C-B), 83.1, 25.0, 17.1,
11B NMR (160 MHz, CDCl3): δ = 33.94.
8.0.
11B NMR (160 MHz, CDCl3): δ = 29.51.
4,4,5,5-Tetramethyl-2-(3-(triethoxysilyl)propyl)-1,3,2-dioxaboro-
lane (2o)
According to General Procedure A, allyltriethoxysilane (1.00 mmol,
0.226 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 18 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2o (215.2 mg, 0.680 mmol, 68%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 3.80 (q, J = 7.0 Hz, 6 H), 1.59–1.50 (m,
2 H), 1.24–1.19 (m, 21 H), 0.85 (t, J = 7.6 Hz, 2 H), 0.70–0.64 (m, 2 H).
13C NMR (126 MHz, CDCl3): δ = 83.0, 58.4, 25.0, 18.4, 17.6, 15.3 (br C-
B), 13.5.
11B NMR (160 MHz, CDCl3): δ = 33.83.
29Si NMR (99 MHz, CDCl3): δ = 45.02.
(E)-4,4,5,5-Tetramethyl-2-(3,3-dimethyl-but-1-enyl)-1,3,2-dioxa-
borolane (2k)
According to General Procedure A, 3,3-dimethyl-1-butyne (1.00
mmol, 0.122 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF
(0.100 mmol, 1 M, 0.100 mL) were reacted for 1 h. The residue was
purified by flash column chromatography (SiO2; hexane/EtOAc, 98:2),
to give boronic ester 2k (170.5 mg, 0.810 mmol, 81%) as a viscous co-
lourless oil.
1H NMR (500 MHz, CDCl3): δ = 6.64 (d, J = 18.3 Hz, 1 H), 5.35 (d,
J = 18.3 Hz, 1 H), 1.27 (s, 12 H), 1.02 (s, 9 H).
13C NMR (126 MHz, CDCl3): δ = 164.6, 112.5 (br C-B), 83.1, 35.2, 29.0,
25.0.
11B NMR (160 MHz, CDCl3): δ = 30.23.
4,4,5,5-Tetramethyl-2-(4-methoxyphenyl-1-ethyl)-1,3,2-dioxa-
borolane (2p)
(Z)-4,4,5,5-Tetramethyl-2-(1-phenyl(prop-1-en)-2-yl)-1,3,2-dioxa-
borolane (2l)
According to General Procedure A, 4-methoxystyrene (1.00 mmol,
0.133 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 18 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2p (175.3 mg, 0.670 mmol, 67%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 7.17–7.10 (m, 2 H), 6.84–6.77 (m, 2 H),
3.78 (s, 3 H), 2.73–2.66 (m, 2 H), 1.22 (s, 12 H), 1.15–1.08 (m, 2 H).
13C NMR (126 MHz, CDCl3): δ = 157.7, 136.7, 129.0, 113.7, 83.2, 55.4,
29.2, 25.0, 13.3 (br C-B).
11B NMR (160 MHz, CDCl3): δ = 33.64.
According to General Procedure A, 1-phenyl-1-propyne (1.00 mmol,
0.125 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 1 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2l (156.2 mg, 0.640 mmol, 64% (75a+25b)) as a colourless
oil. The product was isolated as a mixture of regioisomers (a+b).
1H NMR (500 MHz, CDCl3): δ (major isomer) = 7.41–7.30 (m, 4 H),
7.27–7.14 (m, 2 H), 2.00 (d, J = 1.7 Hz, 3 H), 1.77 (m, 3 H), 1.32 (s,
12 H), 1.27 (s, 9 H).
13C NMR (126 MHz, CDCl3): δ = 142.8, 142.5, 140.0, 138.1, 129.5,
129.2, 128.2, 127.9, 127.2, 126.0, 83.7, 25.0, 24.9, 16.1, 16.0.
11B NMR (160 MHz, CDCl3): δ = 30.23.
4,4,5,5-Tetramethyl-2-(4-tert-butylphenyl-1-ethyl)-1,3,2-dioxa-
borolane (2q)
According to General Procedure A, 4-tert-butylstyrene (1.00 mmol,
0.183 mL), pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100
mmol, 1 M, 0.100 mL) were reacted for 18 h. The residue was purified
by flash column chromatography (SiO2; hexane/EtOAc, 98:2), to give
boronic ester 2q (195.3 mg, 0.840 mmol, 84%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 7.30–7.27 (m, 2 H), 7.17–7.13 (m, 2 H),
2.76–2.67 (m, 2 H), 1.30 (s, 9 H), 1.22 (s, 12 H), 1.17–1.11 (m, 2 H).
13C NMR (126 MHz, CDCl3): δ = 148.4, 141.5, 127.8, 125.2, 83.2, 34.5,
31.6, 29.5, 25.0, 13.1 (br C-B).
11B NMR (160 MHz, CDCl3): δ = 33.66.
4,4,5,5-Tetramethyl-2-(octyl)-1,3,2-dioxaborolane (2m)
According to General Procedure A, 1-octene (1.00 mmol, 0.157 mL),
pinacolborane (1.10 mmol, 0.160 mL), and H3B·THF (0.100 mmol, 1 M,
0.100 mL) were reacted for 18 h. The residue was purified by flash
column chromatography (SiO2; hexane/EtOAc, 98:2), to give boronic
ester 2m (180.2 mg, 0.750 mmol, 75%) as a colourless oil.
1H NMR (500 MHz, CDCl3): δ = 1.45–1.38 (m, 2 H), 1.32–1.25 (m,
10 H), 1.24 (s, 12 H), 0.87 (t, J = 6.9 Hz, 3 H), 0.76 (t, J = 7.8 Hz, 2 H).
13C NMR (126 MHz, CDCl3): δ = 83.0, 32.6, 32.1, 29.5, 29.4, 25.0, 24.2,
22.8, 14.3, 11.1 (br C-B).
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–F